Muscle Strength Training in Lower Limb Amputee Patients
Effects of Muscle Strength Training in Lower Limb Amputee Patients
1 other identifier
interventional
18
0 countries
N/A
Brief Summary
This study is a clinical trial that evaluates the best treatment option using a strength training protocol and an endurance training protocol in patients with lower limb amputations who use prostheses. The protocol consists of 6 weeks of strength training and 6 weeks of endurance training, with a 1-month washout period between the two.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2025
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2025
CompletedStudy Start
First participant enrolled
November 30, 2025
CompletedFirst Posted
Study publicly available on registry
December 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
December 3, 2025
October 1, 2025
2 years
September 22, 2025
November 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in Funcionality
It is assessed using the TUG test, which requires patients to get up from a chair, walk 3 meters, turn around, walk back to the chair, and sit down again. Patients will receive the following instructions: "Get up on the word 'go,' walk to the tape, turn around, walk back to the chair, and sit down."
day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
Changes in quality of life
It is assessed using a self-administered questionnaire called WHOQOL-BREF, which provides a profile of the person's perceived quality of life.
day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
Secondary Outcomes (3)
Changes in Maximum isometric muscle strength
day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
Changes on Movility
day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
Change in Global percepcion of change
assessments were performed at the end each protocol. day 18 and day 24
Study Arms (2)
Muscle strength training
EXPERIMENTALStrength training lasts six weeks, during which submaximal strength percentages ranging from 75% to 90% are worked on. It is performed three times a week and follows a protocol consisting of progressive exercises for the large functional muscle groups relevant to the population being trained.
Endurance training
ACTIVE COMPARATORResistance training will be carried out for 6 weeks, 3 times a week, with exercises prescribed by a protocol with training characteristics defined by bibliography found in the ACSM.
Interventions
Resistance training will be carried out for 6 weeks, 3 times a week, with exercises prescribed by a protocol with training characteristics defined by bibliography found in the ACSM.
Strength training lasts six weeks, during which submaximal strength percentages ranging from 75% to 90% are worked on. It is performed three times a week and follows a protocol consisting of progressive exercises for the large functional muscle groups relevant to the population being trained.
Eligibility Criteria
You may qualify if:
- Patients with unilateral lower limb amputation
- Transtibial and/or transfemoral amputation
- Prosthetized
- Aged 18 to 75 years
- Who sign the informed consent form
You may not qualify if:
- That they are unable to complete the initial assessment
- That they undergo further secondary training
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY DIRECTOR
Mauro S Barone
Ugr
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
September 22, 2025
First Posted
December 3, 2025
Study Start
November 30, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
December 3, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP, ICF
If necessary or required, informed consent and data analysis will be shared.